Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle

Nucleic Acid Therapeutics

Volumn 21, Issue 5, 2011, Pages 323-332

  Chu, Chun Yen ^a   Lee, Shang Chun ^a   Liu, Shyh Shyan ^b   Lin, Yu Ming ^a   Shen, Perng Chi ^b   Yu, Chi ^b   Lee, Kuo Hua ^c   Zhao, Xin ^d   Lee, Jai Wei ^b,e  

^a Graduate Institute of Animal Vaccine Technology   (Taiwan)

^b NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c Hsin Chu Branch Station   (Taiwan)

^d MCGILL UNIVERSITY   (Canada)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALPHA INTERFERON; AMINO ACID DERIVATIVE; ANTIBODY; ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 12; INTERLEUKIN 21; KEYHOLE LIMPET HEMOCYANIN; KEYHOLE LIMPET HEMOCYANIN ANTIBODY; KEYHOLE LIMPET HEMOCYANIN ANTIGEN; MESSENGER RNA; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; DAIRY CATTLE; FEMALE; IMMUNIZATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MILK LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; BASE SEQUENCE; CATTLE; CELL PROLIFERATION; CYTOKINES; DINUCLEOSIDE PHOSPHATES; FEMALE; FREUND'S ADJUVANT; GENE EXPRESSION; HEMOCYANIN; IMMUNE SERA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MILK; OLIGODEOXYRIBONUCLEOTIDES; PREGNANCY; TOLL-LIKE RECEPTOR 9;

BOS; BOVINAE;

EID: 80054747209     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2010.0275     Document Type: Article

References (47)

1. BAUER, S., KIRSCHNING, C.J., HACKER, H., REDECKE, V., HAUSMANN, S., AKIRA, S., WAGNER, H., and LIPFORD, G.B. (2001). Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U. S. A. 98, 9237-9242. (Pubitemid 32743900)
2. BENDIGS, S., SALZER, U., LIPFORD, G.B., WAGNER, H., and HEEG, K. (1999). CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur. J. Immunol. 29, 1209-1218. (Pubitemid 29164167)
3. BROWN, W.C., ESTES, D.M., CHANTLER, S.E., KEGERREIS, K.A., and SUAREZ, C.E. (1998). DNA and a CpG oligonu-cleotide derived from Babesia bovis are mitogenic for bovine B cells. Infect. Immun. 66, 5423-5432. (Pubitemid 29044640)
4. CHEN, Y.F., LIN, C.W., TSAO, Y.P., and CHEN, S.L. (2004). Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice. J. Virol. 78, 1333-1343.
5. CHU, R.S., TARGONI, O.S., KRIEG, A.M., LEHMANN, P.V., and HARDING, C.V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186, 1623-1631. (Pubitemid 27506276)
6. CIANGA, P., MEDESAN, C., RICHARDSON, J.A., GHETIE, V., and WARD, E.S. (1999). Identification and function of neonatal Fc receptor in mammary gland of lactating mice. Eur. J. Immunol. 29, 2515-2513.
7. EBERT, E.C. (2009). Interluekin-21 up-regulates perforin-medi-ated cytotoxic activity of human intra-epithelial lymphocyte. Immunology 127, 206-215.
8. GRAHAM, S.P., SAYA, R., AWINO, E., NGUGI, D., HYANJUI, J.K., HECKER, R., TARACHA, E.L.N., and NENE, V. (2007). Immunostimulatory CpG oliodeoxynucleotides enhance the induction of bovine CD4+ cytotoxic T-lymphocyte responses against the polymorphic immunodominant molecule of the protozoan parasite Theileria parva. Vet. Immunol. Im-munopathol. 115, 383-389. (Pubitemid 46109057)
9. HARTMANN, G., and KRIEG, A.M. (2000). Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164, 944-952. (Pubitemid 30043721)
10. HEMMI, H., TAKEUCHI, O., KAWAI, T., KAISHO, T., SATO, S., SANJO, H., MATSUMOTO, M., HOSHINO, K., WAGNER, H., TAKEDA, K., and SHIZO, A. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745. (Pubitemid 32015992)
11. HUNOLSTEIN, C.V., TELONI, R., MARIOTTI, S., RECCHIA, S., OREFICI, G., and NISINI, R. (2000). Synthetic oligodeox-ynucleotide containing CpG motif induces an anti-polysac-charide type 1-like immue response after immunization of mice with Haemophilus influenzae type b conjugate vaccine. Int. Immunol. 12, 295-303. (Pubitemid 30142701)
12. IOANNOU, X.P., GRIEBEL, P., HECKER, R., BABIUK, L.A., and VAN DRUNEN LITTLE-VAN DEN HURK, S. (2002). The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol. 76, 9002-9010. (Pubitemid 34919859)
13. JAKOB, T., WALKER, P.S., KRIEG, A.M., UDEY, M.C., and VOGEL, J.C. (1998). Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role of dendritic cells in the augmentation of Th1 responses by immunosti-mulatory DNA. J. Immunol. 161, 3042-3049. (Pubitemid 28425730)
14. KAMSTRUP, S., VERTHELYI, D., and KLINMAN, D.M. (2001). Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. Vet. Microbiol. 78, 353-362. (Pubitemid 32162922)
15. KIKUCHI, K., LIAN, Z.-X., KIMURA, Y., SELMI, C., YANG, G.X., GORDON, S.C., INVERNIZZI, P., PODDA, M., COP-PEL, R.L., ANSARI, A.A., IKEHARA, S., MIYAKAWA, H., and GERSHWIN, M.E. (2005). Genetic polymorphisms of tolllike receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J. Auto-immun. 24, 347-352. (Pubitemid 40775859)
16. KLINMAN, D.M., BARNHART, K.M., and CONOVER, J. (1999). CpG motifs as immune adjuvants. Vaccine 17, 19-25. (Pubitemid 28470728)
17. KNUEFERMANN, P., BAUMGARTEN, G., KOCH, A., SCHWEDERSKI, M., VELTEN, M., EHRENTRAUT, H., MERSMANN, J., MEYER, R., HOEFT, A., ZACHAROWSKI, K., and GROHé, C. (2007). CpG oligonucleotide activates Tolllike receptor 9 and causes lung inflammation in vivo. Respir. Res. 8, 72.
18. KONFORTE, D., SIMARD, N., and PAIGE, C.J. (2009). IL-21: an executor of B cell fate. J. Immunol. 182, 1781-1787.
19. KOVACS-NOLAN, J., MAPLETOFT, J.W., LATIMER, L., BA-BIUK, L.A., and VAN DRUNEN LITTEL-VAN DEN HURK, S. (2009). CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle. Vaccine 27, 2048-2054.
20. KRIEG, A.M., YI, A.K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
21. LEE, J.-W., BANNERMAN, D.D., PAAPE, M.J., HUANG, M.-K., and ZHAO, X. (2006). Characterization of cytokine expression in milk somatic cells during intramammary infections with Escherichia coli or Staphylococcus aureus by real-time PCR. Vet. Res. 37, 219-229.
22. LEE, J.-W., O'BRIEN, C.N., GUIDRY, A.J., PAAPE, M.J., SHA-FER-WEAVER, K.A., and ZHAO, X. (2005). The effect of a trivalent vaccine against Staphylococcus aureus mastitis on lymphocyte subpopulations, antibody production, and neu-trophil phagocytosis. Can. J. Vet. Res. 69, 11-18. (Pubitemid 40192586)
23. LEIFER, C.A., VERTHELYI, D., and KLINMAN, D.M. (2003). Heterogeneity in the human response to immunostimulatory CpG oligodeoxynucleotides. J. Immunol. 26, 313-319. (Pubitemid 36858715)
24. LENERT, P., RASMUSSEN, W., ASHMAN, R.F., and BALLAS, Z.K. (2003). Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells. DNA Cell Biol. 22, 621-631. (Pubitemid 37357732)
25. MAPLETOFT, J.W., OUMOUNA, M., TOWNSEND, H.G., GO-MIS, S., BABIUK, L.A., and VAN DRUNEN LITTEL-VAN DEN HURK, S. (2006). Formulation with CpG oligodeox-ynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus. Virology 353, 316-323. (Pubitemid 44397136)
26. MEDESAN, C., CIANGA, P., MUMMERT, M., STANESCU, D., GHETIE, V., and WARD, E.S. (1998). Comparative studies of rat IgG to further delineate the Fc:FcRn interaction site. Eur. J. Immunol. 28, 2092-2100. (Pubitemid 28321292)
27. MEHRZAD, J., JANSSEN, D., DUCHATEAU, L., and BURVE-NICH, C. (2008). Increase in Escherichia coli inoculum dose accelerates CD8 cells trafficking in the premiparous bovine mammary gland. J. Dairy Sci. 91, 193-201. (Pubitemid 351455833)
28. MEHRZAD, J., and ZHAO, X. (2008). T lymphocyte proliferative capacity and CD4+/CD8+ ratio in primiparous and plur-iparous lactating cows. J. Dairy Res. 75, 457-465.
29. MENA, A., NICHANI, A.K., POPOWYCH, Y., IOANNOU, X.P., GODSON, D.L., MUTWIRI, G.K., HECKER, R., BABIUK, L.A., and GRIEBEL, P. (2003). Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by class A and class B CpG-oligodeoxynucleotide. Oligonucleotides 13, 245-259. (Pubitemid 37428816)
30. PARRISH-NOVAK, J., DILLON, S.R., NELSON, A., HAMMOND, A., SPRECHER, C., GROSS, J.A., JOHNSTON, J., MADDEN, K., WEST, J., SCHRADER, S., BURKHEAD, S., HEIPEL, M., BRANDT, C., KUIJPER, J.L., KRAMER, J., CONKLIN, D., PRESNELL, S.R., BERRY, J., SHIOTA, F., BORT, S., HAMBLY, K., MUDRI, S., CLEGG, C., MOORE, M., GRANT, F.J., LOFTON-DAY, C., GILBERT, T., RAYOND, F., CHING, A., YAO, L., SMITH, D., WEBSTER, P., WHITMORE, T., MAURER, M., KAUSHANSKY, K., HOLLY, R.D., and FOSTER, D. (2000). Interleukin-21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408, 57-63
31. PONTAROLLO, R.A., RANKIN, R., BABIUK, L.A., GODSON, D.L., GRIEBEL, P.J., HECKER, R., KRIEG, A.M., and VAN DRUNEN LITTLE-VAN DEN HURK, S. (2002). Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet. Immunol. Immunopathol. 84, 43-59. (Pubitemid 34083578)
32. RANKIN, R., PONTAROLLO, R., GOMIS, S., KARVONEN, B., WILLSON, P., LOEHR, B.I., GODSON, D.L., BABIUK, L.A., HECKER, R., and VAN DRUNEN LITTLE-VAN DEN HURK, S. (2002). CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine 20, 3014-3022. (Pubitemid 34785973)
33. RANKIN, R., PONTAROLLO, R., IOANNOU, X., KRIEG, A.M., HECKER, R., BABIUK, L.A., and VAN DRUNEN LITTLE-CAN DEN HURK, S. (2001). CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11, 333-340. (Pubitemid 33070092)
34. RODA, J.M., PARIHAR, R., and CARSON, W.E., 3rd. (2005). CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. J. Immunol. 175, 1619-1627. (Pubitemid 41023064)
35. SCHNARE, M., BARTON, G.M., HOLT, A.C., TAKEDA, K., AKIRA, S., and MEDZHITOV, R. (2001). Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2, 947-950. (Pubitemid 32976167)
36. SHODA, L.K.M., KEGERREIS, K.A., SUAREZ, C.E., MWANGI, W., KNOWLES, D.P., and BROWN, W.C. (2001). Im-munostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-a, and NO production by bovine macrophages. J. Leukoc. Biol. 70, 103-112. (Pubitemid 32613669)
37. STACEY, K.J., SESTER, D.P., SWEET, M.J., and HUME, D.A. (2000). Macrophage activation by immunostimulatory DNA. Curr. Top. Microbiol. Immunol. 247, 41-58. (Pubitemid 30012399)
38. TAKESHITA, F., LEIFER, C.A., GURSEL, I., ISHII, K.J., TAKE-SHITA, S., GURSEL, M., and KLINMAN, D.M. (2001). Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167, 3555-3558. (Pubitemid 32910795)
39. VERTHELYI, D., ISHII, K.J., GURSEL, M., TAKESHITA, F., and KLINMAN, D.M. (2001). Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166, 2372-2377. (Pubitemid 32173471)
40. WEDLOCK, D.N., DENIS, M., SKINNER, M.A., KOACH, J., DE LISLE, G.W., VORDERMEIER, H.M., HEWINSON, R.G., VAN DRUNEN LITTLE-CAN DEN HURK, S., BABIUK, L.A., HECKER, R., and BUDDLE, B.M. (2005a). Vaccination of cattle with CpG oligodeoxynucleotdie-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induced levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone. Infect. Immun. 73, 3540-3546. (Pubitemid 40745898)
41. WEDLOCK, D.N., SKINNER, M.A., DE LISLE, G.W., VOR-DERMEIER, H.M., HEWINSON, R.G., HECKER, R., VAN DRUNEN LITTLE-VAN DEN HURK, S., BABIUK, L.A., and BUDDLE, B.M. (2005b). Vaccination of cattle with Myco-bacterium bovis culture filtrate proteins and CpG oligodeox-ynucleotides induces protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 106, 53-63. (Pubitemid 40720157)
42. WEERATNA, R.D., MCCLUSKIE, M.J., XU, Y., and DAVIS, H.L. (2000). CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 18, 1755-1762. (Pubitemid 30122837)
43. WEINER, G.J., LIU, H.-M., WOOLDRIDGE, J.E., DAHLE, C.E., and KRIEG, A.M. (1997). Immunostimulatory oligodeox-ynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. U. S. A. 94, 10833-10837.
44. ZHANG, Y., PALMER, G.H., ABBOTT, J.R., HOWARD, C.J., HOPE, J.C., and BROWN, W.C. (2003). CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a reckettsial outer membrane protein in alum. Vaccine 21, 3307-3318. (Pubitemid 36700431)
45. ZHANG, Y., SHODA, L.K., BRAYTON, K.A., ESTES, D.M., PALMER, G.H., and BROWN, W.C. (2001). Induction of in-terleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. J. Interferon Cy-tokine Res. 21, 871-881. (Pubitemid 33078526)
46. ZHANG, L., TIAN, X., and ZHOU, F. (2008). In vivo administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets. Vaccine 26, 224-233.
47. ZHU, F.G., and MARSHALL, J.S. (2001). CpG-containing oli- godeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells. J. Leukoc. Biol. 69, 253-262. (Pubitemid 32163438)